|
27/03/2023 |
Effect and safety of the use of Viusid® on the quality of life of patients with Chronic Kidney Disease on Hemodialysis. |
CATALYSIS |
Registered |
|
27/04/2017 |
Hepatotoxicity by drugs |
CenQfal |
Registered |
|
27/04/2022 |
Evaluation of Clinical Performance of INFANTIX in a Maternity Hospital |
CNEURO |
Registered |
|
27/05/2016 |
COURAGE Study |
CIGB |
Registered |
|
27/05/2021 |
D004 (Palmex) vs Saw palmetto, Finasteride and Tamsulosin in patients with BPH |
CPN |
Registered outdated |
|
27/06/2014 |
D-002 and glucosamine/chondroitin sulphate in osteoarthritis |
CPN |
Registered |
|
27/09/2017 |
Bioequivalence of Abacavir |
CIDEM |
Registered |
|
27/10/2020 |
Prevalence of positive evolutive PCR in patients with COVID 19 treated with rectal ozone therapy: observational study prospective cohort. |
CPN |
Registered outdated |
|
27/10/2020 |
SOBERANA 02 |
FINLAY |
Registered |
|
27/12/2016 |
Policosanol in patients with metabolic syndrome and ischaemic cardiopaty |
CPN |
Registered |
|
27/12/2016 |
Homeostec for the treatment of chronic Chikungunya |
SSA |
Registered |
|
27/12/2024 |
Phase II-III study to evaluate the safety and immunogenicity of the pneumococcal vaccine candidate VCN11 in adult participants aged 50 to 74 years. |
FINLAY |
Registered |
|
28/03/2024 |
Atorvastatin and dexamethasone in adult patients with chronic subdural hematoma; Phase I-II. |
HUPMAD |
Registered |
|
28/04/2017 |
Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II. |
FINLAY |
Registered outdated |
|
28/05/2020 |
Exploratory study of BMT EV to stimulate immune response in patients with CKD-5 on iterated hemodialysis |
BIOCEN |
Registered |
|
28/05/2020 |
ATENEA-Co-300 study |
CIGB |
Registered outdated |
|
28/09/2018 |
Topic Oleozon in patients with epidermophytosis |
CPN |
Registered outdated |
|
28/09/2021 |
SOBERANA PLUS PEDIATRIA |
FINLAY |
Registered outdated |
|
28/11/2016 |
Abexol and Atorvastatin in the non alcoholic steatohepatitis |
CPN |
Registered |
|
28/11/2016 |
NGcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancer |
CIM |
Registered |
